v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 44,815 $ 1,757,024
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change in unrealized (appreciation) depreciation on investments 1,872,006 65,158
Net change in unrealized (appreciation) depreciation on derivative instruments (23,018) 61,350
Net change in unrealized (appreciation) depreciation on foreign currency and other transactions 8,678 (10,138)
Net realized (gain) loss on investments 179,673 36,490
Net realized (gain) loss on foreign currency and other transactions (1,934) (16,434)
Net realized (gain) loss on extinguishment of debt 2,964 794
Net realized (gain) loss on extinguishment of debt   0
Net change due to hedging activity 1,161 (3,219)
Payment-in-kind interest capitalized (213,114) (203,765)
Net accretion of discount and amortization of premium (134,886) (133,659)
Amortization of deferred financing costs 24,852 17,327
Amortization of original issue discount and debt issuance costs (including premiums and discounts) 22,115 19,162
Amortization of offering costs 1,964 2,178
Purchases of investments (6,079,006) (9,746,793)
Proceeds from sale of investments and principal repayments 8,848,548 5,626,022
Changes in operating assets and liabilities:    
Interest receivable (71,617) (15,791)
Dividend receivable 66,039 (8,975)
Receivable from broker (160,127) (39,132)
Receivable for investments (48,732) (186,626)
Other assets 640 0
Payable for investments (7,404) (59,384)
Management fees payable (10,936) 18,671
Income based incentive fees payable (19,419) 7,066
Interest payable 85,821 4,310
Due to affiliates (1,592) (2,276)
Accrued expenses and other liabilities (27,282) (17,821)
Net cash provided by (used in) operating activities 4,360,209 (2,829,255)
Cash flows from financing activities:    
Borrowings on debt 13,115,761 6,388,456
Repayments on debt (12,912,060) (7,525,528)
Deferred financing costs paid (56,900) (12,347)
Debt issuance costs paid (17,402) (21,044)
Deferred offering costs paid (1,381) (1,650)
Proceeds from issuance of Common Shares 1,782,502 6,539,392
Repurchased shares, net of early repurchase deduction paid (5,341,392) (1,111,691)
Dividends paid in cash (1,247,379) (1,101,781)
Net cash provided by (used in) financing activities (4,678,251) 3,153,807
Net increase (decrease) in cash and cash equivalents (318,042) 324,552
Effect of foreign exchange rate changes on cash and cash equivalents (14,663) 7,857
Cash and cash equivalents (including restricted cash), beginning of period 2,348,711 1,650,679
Cash and cash equivalents (including restricted cash), end of period 2,016,006 1,983,088
Supplemental information and non-cash activities:    
Interest paid during the period 1,200,225 1,165,146
Distribution payable 370,535 386,707
Reinvestment of dividends during the period 1,031,217 1,020,638
Accrued but unpaid deferred financing costs 2,009 12
Accrued but unpaid debt issuance costs 1,733 2,234
Accrued but unpaid offering costs 0 0
Share repurchases accrued but not yet paid 2,201,822 1,095,993
Excise and other taxes paid $ 17,342 $ 34,786